✦ LIBER ✦

Adult acute leukemia studies utilizing cytarabine: Early southwest oncology group trials

✍ Scribed by Coltman, Charles A. ;Freireich, Emil J. ;Pendleton, Olga ;Bickers, John N. ;Bodey, Gerald P. ;Hewlett, James S. ;McCredie, Kenneth B.

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 467 KB
Volume: 10
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950100717

No coin nor oath required. For personal study only.

✦ Synopsis

Four Southwest Oncology Group clinical trials in adult acute leukemia were conducted between June 1967 and January 1975 involving 741 adult patients. The trials involved Cytarabine (ARA-C) alone and in combination. The last patient started treatment Over five years ago and 81 of 741 (1 1%) survived more than five years. The last death was at 91 years with followup out to 134 years.

📜 SIMILAR VOLUMES

Management of adult acute leukemia a sou

Management of adult acute leukemia a southwest oncology group study

✍ Kenneth B. McCredie; Edmund A. Gehan; Emil J. Freireich; James S. Hewlett; Charl 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Adriamycin in combination chemotherapy o

Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: A southwest oncology group study

✍ Shaw, Michael T. ;Raab, Spencer O. 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

## Abstract Eighteen (72%) of 25 evaluable and previously untreated patients with adult acute lymphoblastic leukemia entered complete remission (CR) following induction therapy with Adriamycin, vincristine, and prednisone in a Southwest Oncology Group study. Remission maintenance therapy with metho

Early deaths in newly diagnosed cases of

Early deaths in newly diagnosed cases of pediatric acute leukemia. A southwest oncology group study

✍ Stephen L. George; Donald J. Fernbach; Elisa T. Lee 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 3 views

A reanalysis of all ten clinical trials conducted by the Southwest Oncology Group from 1958 through 1976 in newly diagnosed pediatric acute leukemia was carried out to quantify the "early death" rate (i.e., rate of deaths during the first four weeks of remission induction) and to determine factors r

Adriamycin in the treatment of childhood

Adriamycin in the treatment of childhood acute leukemia a southwest oncology group study

✍ Abdelsalam H. Ragab; Wataru W. Sutow; Diane M. Komp; Kenneth A. Starling; George 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

CNS prophylaxis in acute lymphoblastic l

CNS prophylaxis in acute lymphoblastic leukemia. Comparison of two methods a southwest oncology group study

✍ Diane M. Komp; Carlos H. Fernandez; John M. Falletta; Abdelsalam H. Ragab; G. Be 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 3 views

Remission induction in acute myelogenous

Remission induction in acute myelogenous leukemia using cytosine arabinoside synchronization: A southwest oncology group study

✍ Steuber, C. Philip ;Humphrey, G. Bennett ;McMillan, Campbell W. ;Vietti, Teresa 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

The use of cytosine arabinoside (Ara-C) infused at kinetically suggested intervals is reported in 40 pediatric patients with acute myelogenous leukemia (AML) and its subtypes. Response was observed in 17 of the 34 evaluable patients. However, the severe, often fatal effects of the regimen prevent it